Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.

Bonito-Oliva A, Barbash S, Sakmar TP, Graham WV.

Sci Rep. 2017 Feb 21;7:42880. doi: 10.1038/srep42880.

2.

Update on Alzheimer's Disease Therapy and Prevention Strategies.

Graham WV, Bonito-Oliva A, Sakmar TP.

Annu Rev Med. 2017 Jan 14;68:413-430. doi: 10.1146/annurev-med-042915-103753. Review.

PMID:
28099083
3.

Crystallization and preliminary X-ray analysis of the human long myosin light-chain kinase 1-specific domain IgCAM3.

Graham WV, Magis AT, Bailey KM, Turner JR, Ostrov DA.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2011 Feb 1;67(Pt 2):221-3. doi: 10.1107/S1744309110050323. Epub 2011 Jan 22.

4.

The epithelial barrier is maintained by in vivo tight junction expansion during pathologic intestinal epithelial shedding.

Marchiando AM, Shen L, Graham WV, Edelblum KL, Duckworth CA, Guan Y, Montrose MH, Turner JR, Watson AJ.

Gastroenterology. 2011 Apr;140(4):1208-1218.e1-2. doi: 10.1053/j.gastro.2011.01.004. Epub 2011 Jan 13.

5.

Caveolin-1-dependent occludin endocytosis is required for TNF-induced tight junction regulation in vivo.

Marchiando AM, Shen L, Graham WV, Weber CR, Schwarz BT, Austin JR 2nd, Raleigh DR, Guan Y, Watson AJ, Montrose MH, Turner JR.

J Cell Biol. 2010 Apr 5;189(1):111-26. doi: 10.1083/jcb.200902153. Epub 2010 Mar 29.

6.

Epithelial barriers in homeostasis and disease.

Marchiando AM, Graham WV, Turner JR.

Annu Rev Pathol. 2010;5:119-44. doi: 10.1146/annurev.pathol.4.110807.092135. Review.

PMID:
20078218
7.

No static at all.

Graham WV, Marchiando AM, Shen L, Turner JR.

Ann N Y Acad Sci. 2009 May;1165:314-22. doi: 10.1111/j.1749-6632.2009.04050.x.

8.

IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction.

Wang F, Schwarz BT, Graham WV, Wang Y, Su L, Clayburgh DR, Abraham C, Turner JR.

Gastroenterology. 2006 Oct;131(4):1153-63. Epub 2006 Aug 22.

9.
10.

MAPKAPK-2 is a critical signaling intermediate in NHE3 activation following Na+-glucose cotransport.

Hu Z, Wang Y, Graham WV, Su L, Musch MW, Turner JR.

J Biol Chem. 2006 Aug 25;281(34):24247-53. Epub 2006 Jun 22.

11.

Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms.

Reschly EJ, Spaulding C, Vilimas T, Graham WV, Brumbaugh RL, Aifantis I, Pear WS, Kee BL.

Blood. 2006 May 15;107(10):4115-21. Epub 2006 Jan 31.

12.

A strategy to identify stable membrane-permeant peptide inhibitors of myosin light chain kinase.

Owens SE, Graham WV, Siccardi D, Turner JR, Mrsny RJ.

Pharm Res. 2005 May;22(5):703-9. Epub 2005 May 17.

PMID:
15906163
13.

Distinct temporal-spatial roles for rho kinase and myosin light chain kinase in epithelial purse-string wound closure.

Russo JM, Florian P, Shen L, Graham WV, Tretiakova MS, Gitter AH, Mrsny RJ, Turner JR.

Gastroenterology. 2005 Apr;128(4):987-1001.

14.
15.

Phylomat: an automated protein motif analysis tool for phylogenomics.

Graham WV, Tcheng DK, Shirk AL, Attene-Ramos MS, Welge ME, Gaskins HR.

J Proteome Res. 2004 Nov-Dec;3(6):1289-91.

PMID:
15595740
16.

A combined in vitro/bioinformatic investigation of redox regulatory mechanisms governing cell cycle progression.

Conour JE, Graham WV, Gaskins HR.

Physiol Genomics. 2004 Jul 8;18(2):196-205.

PMID:
15138307
17.

Gastrointestinal and microbial responses to sulfate-supplemented drinking water in mice.

Deplancke B, Finster K, Graham WV, Collier CT, Thurmond JE, Gaskins HR.

Exp Biol Med (Maywood). 2003 Apr;228(4):424-33.

PMID:
12671187

Supplemental Content

Loading ...
Support Center